TickerFacts.

Burning Rock Biotech Ltd (BNR): Capital Expenditures

Annual figures by period end, from SEC filings.

5.25M CNY
Year ended 2025-12-31
-56.1%
3-year compound annual growth
-38.6%
5-year compound annual growth
204.33M CNY2018-12-31: 23.19M CNY2019-12-31: 42.97M CNY2020-12-31: 60.29M CNY2021-12-31: 204.33M CNY2022-12-31: 62.03M CNY2023-12-31: 8.10M CNY2024-12-31: 5.42M CNY2025-12-31: 5.25M CNY5.25M CNY
2018-12-31 Capital Expenditures (CNY) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-315.25M CNY-3.1%2026-04-28, From 2025-01-01
2024-12-315.42M CNY-33.1%2026-04-28, From 2024-01-01
2023-12-318.10M CNY-86.9%2026-04-28, From 2023-01-01
2022-12-3162.03M CNY-69.6%2025-04-29, From 2022-01-01
2021-12-31204.33M CNY+238.9%2024-04-29, From 2021-01-01
2020-12-3160.29M CNY+40.3%2023-04-20, From 2020-01-01
2019-12-3142.97M CNY+85.3%2022-04-29, From 2019-01-01
2018-12-3123.19M CNYn/a2021-03-23, From 2018-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Burning Rock Biotech Ltd (BNR)2025-12-315.25M CNY-3.1%
Concord Medical Services Holdings Ltd (CCM)2025-12-3156.32M CNY-62.6%

Compare BNR, CCM side by side · Screen every company in Services-Medical Laboratories ↗